Evidence map›Paper›PMID 30552419›Full record

ArticleNature medicine2019

Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.

Neville K Kisalu, Azza H Idris, Connor Weidle, Yevel Flores-Garcia, Barbara J Flynn, Brandon K Sack, Sean Murphy, Arne Schön, Ernesto Freire, Joseph R Francica and 28 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors.

Neville K Kisalu *Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Azza H Idris *Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Connor WeidleVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Yevel Flores-GarciaMalaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Barbara J FlynnVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Brandon K SackSeattle Biomedical Research Institute, Seattle, Washington, USA.ORCID http://orcid.org/0000-0002-5577-7787
Sean MurphySeattle Biomedical Research Institute, Seattle, Washington, USA.
Arne SchönDepartment of Biology, Johns Hopkins University, Baltimore, Maryland, USA.
Ernesto FreireDepartment of Biology, Johns Hopkins University, Baltimore, Maryland, USA.
Joseph R FrancicaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Alex B MillerDivision of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Jason GregoryMalaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Sandra MarchDivision of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Hua-Xin LiaoDuke Human Vaccine Institute, Durham, North Carolina, USA.
Barton F HaynesDuke Human Vaccine Institute, Durham, North Carolina, USA.
Kevin WieheDuke Human Vaccine Institute, Durham, North Carolina, USA.
Ashley M TramaDuke Human Vaccine Institute, Durham, North Carolina, USA.
Kevin O SaundersDuke Human Vaccine Institute, Durham, North Carolina, USA.
Morgan A GladdenDuke Human Vaccine Institute, Durham, North Carolina, USA.
Anthony MonroeDuke Human Vaccine Institute, Durham, North Carolina, USA.
Mattia BonsignoriDuke Human Vaccine Institute, Durham, North Carolina, USA.
Masaru KanekiyoVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID http://orcid.org/0000-0001-5767-1532
Adam K WheatleyVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Adrian B McDermottVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
S Katie FarneyVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Gwo-Yu ChuangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Baoshan ZhangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Natasha KcSanaria Inc., Rockville, Maryland, USA.
Sumana ChakravartySanaria Inc., Rockville, Maryland, USA.
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Photini SinnisMalaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Sangeeta N BhatiaDivision of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Stefan H I KappeSeattle Biomedical Research Institute, Seattle, Washington, USA.
B Kim Lee SimSanaria Inc., Rockville, Maryland, USA.ORCID http://orcid.org/0000-0002-8598-8905
Stephen L HoffmanSanaria Inc., Rockville, Maryland, USA.
Fidel ZavalaMalaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Marie Pancera *Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. mpancera@fredhutch.org.
Robert A Seder *Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. rseder@mail.nih.gov.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the version of this article originally published, data were incorrectly ascribed to monoclonal antibody CIS34 because of a labeling error. The data were generated with monoclonal antibody CIS04. Full details can be found in the correction notice.

Identifiers

PMID30552419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.